DS in Pharmatics

FEBRUARY 27, 2023

When pharmaceutical companies develop a new drug product for the market, there are many different steps a potential product must go through to determine and control its safety, manufacturability, effectiveness and reliability. CMC is done during […]

Drug Development 52

Drug Development Pharmaceutical Companies Drugs Pharmaceuticals 52

Drug Discovery World

JANUARY 10, 2024

As patent cliffs loom for large pharmaceutical companies, they may choose to do more partnerships, merger and acquisition (M&A) deals with biotechs to enhance their drug development and innovation. Stabilising interest rates may also prompt a return for a more promising outlook.”

Pharmaceutical Companies 288

Pharmaceutical Companies Marketing International Pharmaceuticals 288

Drug Discovery World

JANUARY 23, 2024

Solving bottlenecks in precision medicine R&D Medical trials underpin modern healthcare yet clinical research is an incredibly complex and time-consuming process for both patients and companies running trials, including pharmaceutical companies and emerging biotech startups.

Clinical Trials 130

Clinical Trials Pharmaceutical Companies Trials Drug Development 130

Drug Patent Watch

AUGUST 26, 2024

The pharmaceutical industry has increasingly relied on Contract Development and Manufacturing Organizations (CDMOs) to support the development and commercialization of drugs. CDMOs offer a range of services, from drug development to manufacturing, allowing pharmaceutical companies to focus on their core competencies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drug Development Drugs 59

Drug Discovery World

FEBRUARY 26, 2024

Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market. The global ADME toxicology testing market is predicted to generate a revenue of $19.21

Marketing 147

Marketing Drugs Pharmaceutical Companies Pharmaceuticals 147

Drug Discovery World

SEPTEMBER 26, 2022

It’s common knowledge that drug discovery and development is costly, lengthy and has no guarantee of success. It’s why pharmaceutical companies will often spend up to 10 years and upwards of $1 billion before receiving regulatory approval for a drug. Global efforts .

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials 130

Drug Discovery World

SEPTEMBER 22, 2022

Pfizer has extended its multi-year partnership with CytoReason to use CytoReason’s artificial intelligence (AI) technology for Pfizer’s drug development programs. . Pfizer will make a $20 million equity investment, have options to license CytoReason’s platform and disease models, and fund supplementary project support.

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Licensing Licensing 130

Drug Discovery World

OCTOBER 14, 2022

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies. . billion with a projected growth of 14% per annum 1.

Clinical Trials 130

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 130

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Research Clinical Development Drug Development 98

Drug Discovery World

OCTOBER 2, 2023

Download to find out: Neuroscience drug discovery advances and challenges and how breakthroughs in this field are helping address areas of unmet need The challenges of achieving precision medicine in complex CNS conditions and how precision neuroscience approaches are benefiting pharmaceutical companies The ways human data can benefit neurology drug (..)

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Pharmaceuticals Drug Development 130

Drug Discovery World

JUNE 2, 2023

With National Cancer Research Month coming to an end and the American Society of Clinical Oncology Annual Meeting currently taking place in Chicago (2-6 June), it’s been another busy week for cancer drug development news.

Pharmaceutical Companies 130

Pharmaceutical Companies Clinical Trials Drugs Pharmaceuticals 130

Drug Discovery World

FEBRUARY 13, 2024

AI has long been touted as having the potential to speed up drug development, particularly in the early-drug discovery stages, by helping researchers find suitable drug targets that can better tackle diseases.

Small Molecule 147

Small Molecule Drugs Therapies Pharmaceutical Companies 147

Drug Discovery World

OCTOBER 19, 2023

Until recently many large pharmaceutical companies had stopped antibiotic research as the returns on investment were too low and regulatory requirements too stringent. Bacteria and other microbes are evolving to become resistant to treatment, driven in large part by our overuse of antibiotics.

Pharmaceutical Companies 147

Pharmaceutical Companies Science Treatment Pharmaceuticals 147

The Pharma Data

MAY 5, 2022

Validated Measurable Residual Disease Assays are Critical for the Rapid Development of Future Novel Therapeutics for Patients with Acute Myeloid Leukemia. Most often, AML develops from cells that would turn into white blood cells (other than lymphocytes), but sometimes AML develops in other types of blood-forming cells.

Disease 52

Disease Drug Development Clinical Trials Pharmaceutical Companies 52

Drug Discovery World

JULY 5, 2023

Companion diagnostics are vital for the development of precision oncology treatments which are more targeted, more specific, and are less likely to have side effects. Vendors must respond to the need for agility and resilience in the development of cancer treatments and therapeutics. RA: How is Agilent supporting cancer research?

Research 246

Research Immune Response Pharmaceutical Companies Treatment 246

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. In 2022, the continent held a 22.4%

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Drug Discovery World

SEPTEMBER 15, 2023

Specialist pharmaceutical company Norgine has appointed Saulo Martiniano as its new Chief Operating Officer (COO). Martiniano previously worked at L’Oréal and was responsible for leading Global Manufacturing Excellence across 38 plants that included more than 10,000 employees.

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceuticals Production Marketing 130

H1 Blog

DECEMBER 4, 2023

As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. Let’s dive in to uncover the role of digital health and data in driving faster drug development through improved diversity.

Clinical Trials 59

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals 59

Drug Discovery World

JUNE 15, 2023

Matador was founded to build a bridge between overseas technology firms and Japanese pharmaceutical companies, and collaboration is critical to this aim. Together, the Alliance and Matador will create further networking and interest groups in the Japanese language and time-zone that directly benefit member organisations in the region.

Pharmaceutical Companies 130

Pharmaceutical Companies Science Hospitals Pharmaceuticals 130

DS in Pharmatics

FEBRUARY 24, 2023

Drug development is an immensely complex undertaking consisting of many different, interconnected processes. Specialist regulatory affairs consultants offer services to companies operating across this challenging industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Regulations Pharmaceuticals Drug Development 52

DrugBank

MARCH 7, 2024

The Quest for Ozempic-Like Alternatives Ozempic, a GLP-1 receptor agonist developed by Novo Nordisk, has demonstrated remarkable efficacy in promoting weight loss and improving metabolic health. Key Players and Challenges For pharmaceutical giants like Novo Nordisk and Eli Lilly, 2024 presents both opportunities and challenges.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceuticals Clinical Trials Pharmacokinetics 80

Drug Discovery World

SEPTEMBER 28, 2023

Earlier this year, we explored the microbiome and its role in drug development across various therapeutic areas. Women’s health microbiome-based drug development landscape Despite their limited historical interest, pharma/biotech companies are now increasingly interested in the female microbiome and its role in drug development.

Clinical Trials 162

Clinical Trials Regulations Trials Drug Development 162

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

H1 Blog

JULY 30, 2024

This sets the stage for binding and enforceable components per Section 3601 of the Food and Drug Omnibus Reform Act (FDORA), which will come into effect 180 days after the final guidance is published. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59

FDA Compliance Clinical Trials Pharma Companies 59

Drug Discovery World

DECEMBER 28, 2023

But over the course of my career, I have seen the tides begin to turn as practicing clinicians, researchers, advocacy groups and pharmaceutical companies advance conversations around the needs of our shared north star – the patient. In many ways, it is fortunate that paediatric cancer is considered a rarity by the medical community.

Research 130

Research Clinical Trials Hospitals Trials 130

Drug Discovery World

FEBRUARY 10, 2023

The weakness connected to that is we have so few large pharmaceuticals. The pharma companies that are based in Sweden, are international ones, and often have a marketing and commercial side but maybe not that drug development side that really brings that key focus area between the development and commercialisation.”

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130

thought leadership

JUNE 19, 2023

Across biotech startups and global pharmaceutical companies alike, Veeva Vault continues to expand market share. With 1,300+ customers, Veeva Systems is one of the largest providers of cloud solutions for the life sciences industry.

Pharmaceutical Companies 40

Pharmaceutical Companies Science Pharmaceuticals Drug Development 40

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

At Worldwide, we understand that every program is different, which means every drug development path forward will be unique. Rather than settling for an “off-the-shelf” approach, you deserve a team that actively seeks customized solutions tailored to your specific study.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

Drug Discovery World

NOVEMBER 11, 2022

Pharma companies team-up to reduce emissions . Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. . . . . . The post This week in drug discovery (7-11 November) appeared first on Drug Discovery World (DDW).

Pharma Companies 130

Pharma Companies Drugs Pharmaceutical Companies Disease 130

PPD

JULY 20, 2023

Key competencies for biotech and biopharma organizations to meet the new USP requirements for plastic packaging and manufacturing materials With the implementation date drawing nearer, drug developers should test their packaging systems to ensure they are compliant and adhere to patient safety goals, or quickly identify and qualify alternatives.

Packaging 52

Packaging Laboratories Pharmaceutical Companies Compliance 52

PPD

JUNE 20, 2024

To accelerate clinical research timelines, pharmaceutical developers need to tap into solutions that demonstrably streamline drug development from start to finish. The finish line: Powering your success It’s time for pharmaceutical developers to make clinical research timelines work for them, not against them.

Clinical Research 52

Clinical Research Research Pharmaceuticals Clinical Trials 52

DrugBank

APRIL 12, 2024

Over the past decade, the drug discovery landscape has been revolutionized by the adoption of artificial intelligence (AI) and machine learning (ML), witnessing early adopters leapfrog into pioneering technologies aimed at streamlining the drug development process and curtailing associated costs.

Drugs 82

Drugs Pharmaceutical Companies Clinical Trials Pharmaceuticals 82

H1 Blog

SEPTEMBER 14, 2023

As pharmaceutical companies turn to CROs (Clinical Research Organizations) for trial design and technology, there are new opportunities emerging with healthcare data intelligence that can help ensure a bright future for the industry and to make trials more effective, efficient and accessible. million data points.”

Clinical Trials 59

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 59

Altus Drug Development

JUNE 30, 2022

While this strategy is widely adopted by modern pharmaceutical companies, in recent years, its effectiveness has begun to wane. This novel approach promises to create great advantages for the pharmaceutical companies who adopt it and might become the future of medicine.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Production 52

FDA Law Blog: Drug Discovery

MARCH 6, 2024

Charles assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues.

FDA 59

FDA Compliance Pharmaceuticals Regulations 59

Drug Target Review

AUGUST 15, 2023

Prochownik, delved into the dual role of the Myc gene in both cancer development and ageing. The findings highlight the gene’s complex functions, opening up new avenues for cancer therapy and raising important considerations for future drug development.

Research 98

Research Pharmaceutical Companies Drug Development Therapies 98